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Genotype-Specific Recurrence Risks as Indicators
of the Genetic Architecture of Complex Diseases
Montgomery Slatkin1,*
A statistic is introduced that relates discoveries made in genome-wide association (GWA) studies to patterns of disease risks among rel-
atives. The genotype-speciﬁc recurrence risk (GSR) is the genotype-speciﬁc risk to relatives of known relationship to affected probands.
The GSRs can be used for three purposes. (1) They can provide an independent test of whether an allele identiﬁed in a GWA study is
associated with the disease. (2) They can provide a test of whether interactions among loci affecting the disease are multiplicative.
(3) They can be used by genetic counselors to incorporate information from GWA studies for predicting the risk to relatives of known
genotype. Under a multiplicative model of disease causation, the GSRs for a locus are the genotypic risks in probands for that locus mul-
tiplied by lR/ljR, where lR is Risch’s recurrence risk ratio and ljR is the contribution to lR from the locus of interest. If there is saturation of
risk with increasing numbers of causative alleles, then observed GSRs for individuals with high-risk genotypes will be lower than pre-
dicted by the multiplicative model.Complex inherited diseases are affected by many genes.
Although genome-wide association (GWA) studies have
detected numerous single-neucleotide polymorphisms
(SNPs) associated with elevated risk of inherited diseases,
the ways in which causative alleles interact, the extent to
which they are comparable in their effects on disease
risk, and their utility for genetic counseling are not well
understood. Here, I introduce a new set of statistics that
quantify the extent of risk to relatives of affected individ-
uals. The idea is closely related to affected-relative pair
(ARP) methods of gene mapping.1 In those methods, an al-
lele that is shared between affected relatives signiﬁcantly
more often than expected from their relationship indicates
disease association. As noted by Risch,1,2 allele frequencies
at each locus and the way loci interact affect the probabil-
ity of allele sharing in affected-relative pairs and hence the
power of ARP mapping.
In this paper, I reverse the information ﬂow. If an allele
has already been identiﬁed in a GWA study as being signif-
icantly associated with a disease, then the genotype-
speciﬁc risks to relatives of cases in the GWA study can
be estimated and those estimates can be compared with
predictions made under a multiplicative model of interac-
tions among loci. Testing groups of relatives of known re-
lationship can both conﬁrm the association found in the
GWA study and indicate whether interactions among loci
deviate signiﬁcantly from the multiplicative model. In
the following sections, I ﬁrst deﬁne the genotype-speciﬁc
recurrence risks (GSRs) and derive an expression for them
under themultiplicative model of risk. Then, I present sim-
ulation results that demonstrate that GSRs predicted from
themultiplicativemodel differ substantially from observed
values if themultiplicativemodel is not valid. In particular,
if interactions among loci result in saturation of risk
(meaning that risk does not continue to increase with in-
creasing numbers of causative alleles), predicted GSRs for1Department of Integrative Biology, University of California, Berkeley, CA 9
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nally, although no data are available to test the predictions
made here, the feasibility of using the GSRs is illustrated
by using allele frequencies and genotypic risks for a SNP
associated with risk of age-related macular degeneration
(AMD).
Genotype-Speciﬁc Recurrence Risk
The recurrence risk, denotedbyKR
3whereR indicates the re-
lationship (sibling,half-sibling, etc.), of an inheriteddisease
is the probability that a relative of an affected individual is
also affected. Risch3 introduced the risk ratio, lR ¼ KR/K,
where K is the prevalence of the disease, and showed that
under a multiplicative model of interactions among loci,
lR is the product of effects attributable to each locus,
lR ¼
YL
j¼1
ljR: (1)
The ljR are computed from the genotype frequencies and
genotype-speciﬁc contributions to risk from each locus.
The GSRs are related to the risk ratios. Assume that an al-
lele A at locus j is associated with increased disease risk. Let
the average risk to individuals with 2, 1, or 0 copies of A be
wj,2, wj,1, and wj,0. It is shown in Appendix A that, for the
multiplicative model, the disease risk in a relative with re-
lationship R who carries k ¼ 2, 1, or 0 copies of A is
r
ðRÞ
j,k ¼ wj,k

lR
ljR

: (2)
The quantities on the right hand side of Equation (2) can
all be estimated. The risk ratio, lR, is estimated from family
studies, and ljR is estimated from results obtained in the
GWA study.
Calculations analogous to those presented in Appendix
A show that Equation (2) can be generalized to sets of4720-3140, USA
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two or more unlinked loci. For example, if two loci, j and j0,
are identiﬁed as causative in a GWA study, then the geno-
type-speciﬁc risk in relatives can be shown to be
r
ðRÞ
jj0,kk0 ¼ wj,kwj0,k0
 
lR
ljRlj0R
!
(3)
under the multiplicative model.
Simulation Study
In order to determine how well the GSRs are predicted
when the risk model is not multiplicative, I carried out
a simulation study. Each simulation has several steps.
First, the model of risk and its parameters are chosen.
In some cases, this requires the random generation of
parameters for each locus according to rules speciﬁed
below. Second, allele frequencies at each locus are deter-
mined in such a way that the prevalence (K) of the dis-
ease is close to a speciﬁed value. Third, with the risk
model and set of allele frequencies determined, observ-
able statistics are estimated by randomly generating ge-
notypes of pairs of individuals, computing the statistics
for each pair, and then taking the average of a large num-
ber of replicate pairs. In a single simulation, neither the
parameters of the risk model nor the set of allele frequen-
cies change.
The model of risk assumes L diallelic loci, with one allele
(denoted by þ) associated with increased risk. The fre-
quency of þ at each locus is pj and the loci are assumed
to be at Hardy-Weinberg and linkage equilibrium. The ge-
notype of each locus is denoted by kj, which takes values 2,
1, and 0 if the locus has 2, 1, or 0þ alleles. The genotype of
an individual is denoted by a L-vector k¼ {k1,., kL}. I con-
sidered three models of the dependence of risk f on k: the
unconstrained multiplicative, the constrained multiplica-
tive, and the threshold models.
In the unconstrained multiplicative model, the contri-
bution of genotype k at locus j, uj,k, to overall risk is uj,2 ¼
b1/L(1þrj), uj,1 ¼ b1/L(1þhjrj), and uj,0 ¼ b1/L. The overall
risk is the product across loci:
f ðkÞ ¼
YL
j¼1
uj,k: (4)
The parameter b is the background risk and the rj are the
maximum effects of each locus. In the simulations, either
the rj are random variables drawn from an exponential dis-
tribution with a speciﬁedmean, or they are all set to a spec-
iﬁed value. The hj are the dominance parameters, which are
either drawn randomly and independently of the rj from
a uniform distribution on (0,1) or set to a speciﬁed value.
For some parameter values, f determined by Equation (4)
exceeds 1 for some genotypes. In the unconstrained multi-
plicative model, values of f > 1 are allowed. The con-
strained multiplicative model is the same as the uncon-
strained model except that, if the value in Equation (4)
is > 1, f is set to 1.ThThe threshold model comes from quantitative genetics.
The model assumes that disease risk depends on an under-
lying liability, z, which is the sum of a genetic component,
x, and an environmental component, e. The genetic com-
ponent is the sum of contributions of each locus:
xðkÞ ¼PLj¼1 vjðkjÞ, where vj(2)¼ sj, vj(1)¼ hjsj, and vj(0)¼ 0.
The sj are either set to the same speciﬁed value or are gen-
erated from an exponential distribution with a speciﬁed
mean. The hj are either set to the same speciﬁed value or
generated from a uniform distribution on (0, 1). The envi-
ronmental component, e, is assumed to be a normally dis-
tributed random variable that is independent of x and has
mean 0 and variance s2e . The model assumes there is
a threshold value of liability, T: the risk is b if z < T and 1
otherwise. With these deﬁnitions,
f ðkÞ ¼ bþ 1
2
ð1 bÞerfc
h
ðT  xðkÞÞ=

se
ﬃﬃﬃ
2
p i
, (5)
where erfc is the complementary error function,
erfcðzÞ ¼ ð2= ﬃﬃﬃpp Þ RNz expðt2Þdt. If se < 1/4, f is equivalent
to a step function, considered by Lindsey.4 If se < 1/4
and 0 < T < 1, the threshold model is equivalent to the
heterogeneous model analyzed by Risch.3 For larger values
of se, f is a sigmoid function of x centered at x ¼ T.
For each risk model, allele frequencies are generated ran-
domly and independently of rj and hj with a speciﬁed coef-
ﬁcient of variation, CV. This is done by ﬁrst generating a set
of frequencies from a beta distribution with mean 1/2 and
coefﬁcient of variation CV. Then, each frequency is multi-
plied by a factor that is adjusted until the prevalence K is
between 0.009 and 0.011. The coefﬁcient of variation is
preserved when each frequency is multiplied by the same
factor.
In each simulation, K is estimated when the pj are deter-
mined. The next step is to estimate the genotype-speciﬁc
risks in probands (wj,k) by randomly generating replicate
individuals with speciﬁed genotypes at each locus (kj ¼ 2,
1, 0) and averaging over replicates. To estimate recurrence
risks and GSRs, genotypes of pairs of relatives at each locus
with various relationships are drawn independently from
the joint probabilities of genotypes of relatives in an out-
bred population. Independently drawing genotypes for
each locus is equivalent to assuming the loci are unlinked.
The simulated genotype-speciﬁc recurrence risks (r
ðRÞ
j,k ) are
found by conditioning on speciﬁc genotypes at each locus
in the relatives and taking averages over the remaining
loci. The predicted GSRs, denoted by brðRÞj,k , are computed
from Equation (2). The results in all the ﬁgures were based
on averages over 106 replicate pairs.
The ﬁgures show results only for full siblings (R ¼ S), but
the program produces results for ﬁrst (parent-offspring),
second (half-siblings), and third (ﬁrst cousins) degree rela-
tives also. The patterns for these other classes of relatives
are the same as for full siblings, but the effects are weaker
in second and third degree relatives because the risk ratios
are smaller.e American Journal of Human Genetics 83, 120–126, July 2008 121
Figure 1. Predicted and Simulated Values of GSRs
Comparison of predicted and simulated values of the genotype-specific risk ratios (GSRs) in full siblings, r
ðSÞ
j,k, in the three models of
disease risk defined in the text. In all cases, L ¼ 25, b ¼ 106, h ¼ 0.5, CV ¼ 0.75, and all results are based on 106 replicates of the
simulation program described in the text.
(A) Unconstrained multiplicative model with rj ¼ 2 for all j. For the set of parameter values used, K ¼ 0.0104 and lS ¼ 4.65.
(B) Constrained multiplicative model with rj ¼ 2 for all j (K ¼ 0.00972, lS ¼ 4.56).
(C) Threshold model with sj ¼ 1 for all j, T ¼ 12, and se ¼ 1.5 (K ¼ 0.00924 and lS ¼ 4.43).Simulation Results
In the ﬁrst set of results, parameter values are the same at
all loci. In all three models, hj ¼ 1/2. In both multiplicative
models, rj¼ 2 and in the thresholdmodel sj¼ 1.With these
restrictions, the models are exchangeable, meaning that
the risk depends only on the numbers of loci homozygous
and heterozygous for the þ allele, and not on the geno-
types at individual loci. In all cases, L ¼ 25, CV ¼ 0.75,
and frequencies were adjusted so that 0.009 < K < 0.011.
These parameter values were chosen so that the average ef-
fect of each locus and the recurrence risk to full siblings
(lS z 5) are comparable to what was found by Maller
et al.5 in their study of AMD (discussed below). Results
for other parameter values are similar.
In Figure 1A, the predicted and observed values of r
ðSÞ
j,k are
shown for the unconstrained multiplicative model. As122 The American Journal of Human Genetics 83, 120–126, July 200expected, the observed (ﬁlled symbols) and expected
(open symbols) values are essentially the same. Similar re-
sults were obtained with h ¼ 0 and h ¼ 1.
Figure 1B shows that the simulated and predicted
values of r
ðSÞ
j,k are no longer equal for the constrained mul-
tiplicative model. For the high-risk genotype, brðSÞj,2 > rðSÞj,2 .
The threshold model, with parameters chosen to have
roughly the same lS, yields results similar to the con-
strained multiplicative model. For both models, relatives
with the high-risk genotypes have a lower risk than is
predicted by the multiplicative model. The reason is
that risk saturates with the number of loci carrying caus-
ative alleles. If an individual has a high-risk genotype at
one locus, there is less potential for high-risk genotypes
at other loci to increase risk in those models than there
is in the unconstrained multiplicative model. Figure 2Figure 2. Comparison of Predicted and Simulated GSRs
Graphical comparison of simulated and predicted values of the GSRs for the high-risk genotype (k ¼ 2) in full siblings, rðSÞj,2, in the three
models of disease risk defined in the text. The data are from Figure 1 for k ¼ 2. The 45 lines are drawn to facilitate comparison.8
Figure 3. Effects of Varying Allelic Contributions to Risk
Comparison of predicted, brðSÞj,k, and simulated, rðSÞj,k, values of the GSRs in full siblings with genotypes þ/þ (k ¼ 2) (A), þ/ (k ¼ 1) (B),
and / (k ¼ 0) (C) in the threshold models in which the rj vary among loci but h ¼ 0.5 for every locus. The parameters are the same as
in the threshold model in Figures 1 and 2, except that the sj are drawn from an exponential distribution with mean 1 (K ¼ 0.01097 and
lS ¼ 4.13).shows the systematic difference for the high-risk geno-
types in another way that makes the patterns easier to
visualize.
If loci differ in their effects on risk (i.e., rj or sj vary), the
results are essentially the same, as illustrated in Figure 3 for
the threshold model. The GSRs for the high-risk genotypes
differ substantially from the predictions of the multiplica-
tive model. Similar results are obtained when the hj also
vary among loci, as shown in Figure 4.
Example
To illustrate how the theory presented here can be applied,
I use parameter values for a locus associated with elevated
risk of AMD (MIM 603075), the leading cause of blindness
among elderly people in developed countries. Maller et al.5
presented evidence that ﬁve SNPs are associated with
higher risk of AMD and that together they accounted forTh33%–67% of the recurrence risk to full siblings. Maller
et al. could not reject a multiplicative model of interaction
among these SNPs, even though the relatively large effects
on risk gave their test of deviations from the multiplicative
model considerable power. Effect sizes are larger than in
more recent GWA studies but the potential use of the
data is the same.
For one SNP, rs10490924 (MIM 61131) on chromosome
10, the frequency of T among cases was 0.455 and among
controls 0.194 (Table 2 in Maller et al.). From the assump-
tion of multiplicative interactions within a locus, these ob-
servations imply w2/w0 ¼ 12.03 and w1/w0 ¼ 3.45. The ab-
solute risks are age dependent. Vingerling et al.6 estimated
the prevalence of AMD in the Rotterdam study to be 1.7%,
with risk increasing from 0.1% in individuals 55–64 to
3.7% for individuals older than 85. If w0 is set to 0.017,
w2 ¼ 0.204 and w1 ¼ 0.059.Figure 4. Effects of Varying Allelic Contributions and Heritabilities
Comparison of predicted, brðSÞj,k, and simulated, rðSÞj,k, values of the GSRs in full siblings with genotypes þ/þ (A), þ/ (B), and / (C) in
the threshold models in which the rj and hj vary among loci. The parameters are the same as in the threshold model in Figures 1 and 2,
except that se ¼ 2, the sj are drawn from an exponential distribution with mean 1, and the hj are drawn from a uniform distribution on
(0,1). For the set of parameter values used, K ¼ 0.0109 and lS ¼ 4.89.e American Journal of Human Genetics 83, 120–126, July 2008 123
Maller et al.5 estimated the contribution of rs10490924
to overall recurrence risk in full siblings (corresponding
to ljS above) to be 1.45 and reported that estimated values
of lS were in the range 3–6. With the average lS ¼ 4.5, the
above theory predicts that r
ðSÞ
2 ¼ 0:20434:5=1:45 ¼ 0:633
and r
ðSÞ
1 ¼ 0:05934:5=1:45 ¼ 0:183. These are the esti-
mated risks to a proband’s full sibling carrying 2 and 1 cop-
ies of T at rs10490924 under the multiplicative model. The
conﬁdence intervals of these estimates have to reﬂect the
uncertainty in both lS and ljS. If we assume the uncertainty
in lS dominates and use the range 3–6 as a conﬁdence in-
terval, then 0:422 < r
ðSÞ
2 < 0:844 and 0:039 < r
ðSÞ
1 < 0:079
under the assumption of the multiplicative model.
As described in the Summary, there are three ways these
predictions can be used. The ﬁrst is to provide conﬁrma-
tion of the correlation between T at rs10490924 and
AMD. To illustrate, assume a group of full siblings of the
cases in the Maller et al. study can be tested for AMD and
that n of that group has genotype TT. If T were in fact
not associated with AMD, then the risk conditional on
the genotype at rs10490924 is just the risk expected in
full siblings, r
ðSÞ
2 ¼ 0:01736 ¼ 0:102 where the upper
bound of lS is used to be conservative. If n ¼ 100, then
observing 19 or more affected TT full siblings would reject
the null at the 1% level, by a one-tailed binomial test.
A second use of these predictions is to test the hypothe-
sis of multiplicative interactions. If we use the lower bound
of the predicted value of r
ðSÞ
2 , 0.422, and again assume
n¼ 100, then observing 30 or fewer TTaffected full siblings
would reject the multiplicative model at the 1% level by
a one-tailed binomial test.
A third use of these predictions is for genetic counseling.
For example, an individual who is homozygous for T at
rs10490924 and whose full sibling has AMD can be told
that the (non-age-adjusted) chance of getting AMD is
between 42.2% and 84.4%, provided that further study
conﬁrms that rs10490924 is associated with AMD in the
population to which the individual belongs and that a
model of multiplicative interactions among loci is valid.
Discussion and Conclusions
This report shows that standard population genetics the-
ory can be used to predict genotype-speciﬁc risks in rela-
tives of affected probands, thereby providing (1) another
way to test whether SNPs identiﬁed in a GWA study are
causative, (2) another way to test whether the multiplica-
tive model of gene interactions across loci applies, and
(3) information needed to counsel relatives of affected
individuals. The main result is that the genotype-speciﬁc
risks to relatives of affected individuals are increased by
a factor that may be nearly as large as lR.
It is becoming accepted that results from GWA studies
offer little to genetic counselors. For example, the Well-
come Trust Consortium7 concluded, ‘‘These estimates
demonstrate the limited potential of the variants thus far
identiﬁed (singly or in combination) to provide clinically
useful prediction of disease.’’ That is true for individuals124 The American Journal of Human Genetics 83, 120–126, July 200of known genotype at one or more SNPs identiﬁed as con-
ferring higher risk. The increase in risk is too small to be of
much predictive value. For relatives of cases, however, the
increase in risk may be substantially larger. For example, if
lS ¼ 5 and the high-risk genotype of an identiﬁed SNP has
a 20% higher risk, then a sibling with the high-risk geno-
type has a risk almost 6 times higher than the background
risk if the multiplicative model is valid.
The simulations veriﬁed that the predictions made by
the analytic theory for the unconstrained multiplicative
model were correct and also showed that if risk does not
continue to increase with increasing numbers of causative
alleles, predicted GSRs for the high-risk genotypes are too
large. The unconstrained multiplicative model is widely
used in theoretical studies both because of its mathemati-
cal simplicity and because it embodies the parsimonious
idea that each locus contributes to risk independently. Fur-
thermore, several studies, including that of Maller et al.,5
have found no signiﬁcant deviation from a multiplicative
model of interactions among loci. However, as has been
shown elsewhere,8 it is difﬁcult to parameterize the multi-
plicative model in such a way that the average risk (K) is
low (z0.01), the risk ratio to full siblings lS is relatively
high (z5), and the risk is%1 for all genotypes. The reason
is that low K and high lS together require a large variance in
risk among genotypes found in signiﬁcant frequency in
the population.9 The only way to have a high variance
in risk and still ensure that f % 1 is to carefully adjust the
parameters so that f ¼ 1 for an individual homozygous
for high-risk alleles at every causative locus.8 It is likely,
however, that the number of potentially causative loci ex-
ceeds the number needed to create signiﬁcant risk. In that
case, individuals with even more causative alleles will have
f > 1 under the unconstrained multiplicative model.
Constraining the multiplicative model so that f % 1
results in little change in either K or lS because they are
determined by the genotypes in highest frequency in a
population. Genotypes that result in f > 1 will have such
low frequencies that setting their risks to 1 does not change
K or lS bymuch. As we have seen, however, that constraint
does affect the GSRs. The reason is that, under the uncon-
strained multiplicative model, relatives of affected individ-
uals are predicted to have unfeasibly high risks with signif-
icant probability. If instead the risk model implies that
there is saturation of risk with increasing numbers of caus-
ative alleles, as is the case for both the constrained multi-
plicative model and the threshold model, then relatives
with high-risk genotypes have risks lower than predicted
by the unconstrainedmultiplicative model. Consequently,
detecting a lower-than-predicted genotype-speciﬁc recur-
rence risk indicates saturation of the risk as a function of
the number of causative alleles.
The theory presented in the previous sections assumes
that the allele identiﬁed in a GWA study is causative and
not simply in linkage disequilibrium with a causative al-
lele. Linkage to a causative allele would make no difference
provided that the two loci are closely enough linked that8
no recombination between them is likely during the meio-
ses separating the relatives. For GWAs based on 500,000 or
more SNPs, implying an average map distance on the order
of 0.01 cM between adjacent SNPs, that condition is al-
most certainly satisﬁed.
The GSR statistics for full siblings, r
ðSÞ
k , are similar to
Rybicki and Elston’s10 conditional recurrence risk ratio, lS,
which is the recurrence risk ratio in relatives of probands
having a speciﬁc ‘‘at risk’’ genotype. The difference is
that r
ðSÞ
k is estimated from siblings of all affected probands
whereas lS is estimated from siblings of only those pro-
bands with a speciﬁc genotype. Appendix B derives a for-
mula for lS for the unconstrained multiplicative model.
Although the two sets of statistics are closely related, lS
cannot as easily be expressed in terms of observable quan-
tities.
The results presented here add support the point made
by Clerget-Darpoux and Elston11 and others that family
studies can provide important additional information in
this era of GWAs. Unrelated individuals are essential for
successful GWAs, but related individuals provide informa-
tion that is not available even from large samples of unre-
lated individuals. Determining the genotype-speciﬁc risks
to relatives of cases in a case-control study will minimize
the effects of population heterogeneity and other factors,
including the tendency for estimated effects of alleles iden-
tiﬁed in GWA studies to be biased upwards,12 that contrib-
ute to difﬁculties in replicating associations with disease
risk when independent populations are used.
Appendix A
The genotype-speciﬁc recurrence risks (GSRs) deﬁned in
the text can be computed from the multiplicative model
via methods similar to those of Risch.3 Assume that locus
j of L loci has been identiﬁed as having a causative allele,þ.
Let gX,j and gY,j be the genotypes at locus j of the proband
(denoted by X) and the relative with relationship R (de-
noted by Y): gX,j, gY,j ¼ 2, 1, or 0, if the individual carries
2, 1, or 0 copies of þ at locus j.
Let X and Y be the affected status of the two relatives.
The GSR for locus j is deﬁned to be
r
ðRÞ
j,k ¼ PrðY ¼ 1 jX ¼ 1,gY,j ¼ kÞ (A1)
for k ¼ 2, 1, 0.
Under the multiplicative model, X ¼QLj¼1xj and
Y ¼QLj¼1yj, where xj and yj are the contributions of locus
j to the overall risk:
Prðxj ¼ 1 j gX,j ¼ kÞ ¼ Prðyj ¼ 1 j gY,j ¼ kÞ ¼ uj,k:
For unconstrained multiplicative model, we recall from
Risch3
K ¼ PrðX ¼ 1Þ ¼
YL
j¼1
Pr

xj ¼ 1
 ¼YL
j¼1
Kj, (A2)Thwhere Kj ¼ p2j uj,2 þ 2pjð1 pjÞuj,1 þ ð1 pjÞ2uj,0, and pj is
the frequency of þ at locus j, and
lR ¼ PrðY ¼ 1 jX ¼ 1Þ
K
¼
YL
j¼1
Prðyj ¼ 1 j xj ¼ 1Þ
Kj
¼
YL
j¼1
ljR:
(A3)
Furthermore, the average risk given the genotype at
locus j is
wj,k ¼ PrðY ¼ 1 j gY,j ¼ kÞ ¼ uj,k
Y
j0sj
Kj0 : (A4)
where the product is over all j0 (1% j0 % L) except j0 ¼ j.
From these equations it follows that
PrðY ¼ 1 jX ¼ 1,gY,j ¼ kÞ ¼ uj,k
Q
j0sj
Prðyj0 ¼ 1 j xj0 ¼ 1Þ
¼ uj,k
Q
j0sj
Kj0
Q
j0sj
Prðyj0 ¼1 j xj0 ¼1Þ
Kj0
¼ wj,k

lR
lj,R

:
(A5)
This result can be generalized to any number of loci iden-
tiﬁed as causative.
Appendix B
The GSR statistics deﬁned in the text are closely related to
the conditional relative risks deﬁned by Rybicki and El-
ston.10 The conditional risk for genotype k at locus j, lk,R,
is deﬁned to be
lk,R ¼ PrðY ¼ 1 jX ¼ 1,gX,j ¼ kÞ (A6)
where, as above, X denotes the affected status of the pro-
band and Y denotes the affected status of the relative.
Note that in Equation (A6), the conditioning is on gX,j
whereas in Equation (A1) it is on gY,j.
With the assumption of independence across loci,
PrðY ¼ 1 jX ¼ 1,gX,j ¼ kÞ ¼ Prðyj ¼ 1 j xj ¼ 1,gX,j ¼ kÞ
3
Q
j0sj
Prðyj0 ¼ 1 j xj0 ¼ 1Þ
¼ Prðyj ¼ 1 j xj ¼ 1,gX,j ¼ kÞ
Q
j0sj
Kj0
Q
j0sj
lj0R:
(A7)
To evaluate the remaining conditional probability, we
use the fact that, given the genotype at locus j in the pro-
band (gX,j), the contribution of locus j to the risk in the rel-
ative (yj) depends only on gX,j and the relationship, and not
on the contribution of locus j to the risk in the proband
(xj):
Prðyj ¼ 1 j xj ¼ 1,gX,j ¼ kÞ ¼
P2
k0¼0
Prðyj ¼ 1 j gY,j ¼ k0Þ
3PrðgY,j ¼ k0 j gX,j ¼ kÞ
¼ P2
k0¼0
uj,k0PrðgY,j ¼ k0 j gX,j ¼ kÞ:
(A8)e American Journal of Human Genetics 83, 120–126, July 2008 125
where the conditional probability is obtained from the
Hardy-Weinberg frequencies and the probabilities of iden-
tity by descent in pairs of relatives. Substituting in Equa-
tion (A7) yields
PrðY ¼ 1 jX ¼ 1,gX,j ¼ kÞ ¼

lR
ljR
X2
k0¼0
wj,k0
3PrðgY,j ¼ k0 j gX,j ¼ kÞ:
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